Sensorion to Attend Three Conferences in May 2021 Including ASGCT to Present a Poster and Co-Chair a Scientific Session
(0) Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces the participation of members of the company's senior management team in three R&D and investor conferences being held virtually during May 2021. Sensorion's Head of CMC Gene Therapy Christine le Bec will co-chair a scientific session on the " Development of AAV Capsid Variants" at the American Society of Gene Cell Therapy (ASGCT) Annual meeting, ta...
Source: finanznachrichten.de